Results: 1-9 |
Results: 9

Authors: Cocuzza, AJ Chidester, DR Cordova, BC Jeffrey, S Parsons, RL Bacheler, LT Erickson-Viitanen, S Trainor, GL Ko, SS
Citation: Aj. Cocuzza et al., Synthesis and evaluation of efavirenz (Sustiva (TM)) analogues as HIV-1 reverse transcriptase inhibitors: Replacement of the cyclopropylacetylene side chain, BIOORG MED, 11(9), 2001, pp. 1177-1179

Authors: Cocuzza, AJ Chidester, DR Cordova, BC Klabe, RM Jeffrey, S Diamond, S Weigelt, CA Ko, SS Bacheler, LT Erickson-Viitanen, SK Rodgers, JD
Citation: Aj. Cocuzza et al., 4,1-Benzoxazepinone analogues of efavirenz (Sustiva (TM)) as HIV-1 reversetranscriptase inhibitors, BIOORG MED, 11(11), 2001, pp. 1389-1392

Authors: Benz, CC Hilakivi-Clarke, L Conzen, S Dorn, RV Fleming, GF Grant, K Greene, G Hellman, S Henderson, C Hoover, R Hryniuk, W Jeffrey, S Lippman, M Lung, J Mitchell, M Pike, M
Citation: Cc. Benz et al., Expedition inspiration consensus 2001, BREAST CANC, 70(3), 2001, pp. 213-219

Authors: Kaltenbach, RF Trainor, G Getman, D Harris, G Garber, S Cordova, B Bacheler, L Jeffrey, S Logue, K Cawood, P Klabe, R Diamond, S Davies, M Saye, J Jona, J Erickson-Viitanen, S
Citation: Rf. Kaltenbach et al., DPC 681 and DPC 684: Potent, selective inhibitors of human immunodeficiency virus protease active against clinically relevant mutant variants, ANTIM AG CH, 45(11), 2001, pp. 3021-3028

Authors: Bacheler, L Jeffrey, S Hanna, G D'Aquila, R Wallace, L Logue, K Cordova, B Hertogs, K Larder, B Buckery, R Baker, D Gallagher, K Scarnati, H Tritch, R Rizzo, C
Citation: L. Bacheler et al., Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy, J VIROLOGY, 75(11), 2001, pp. 4999-5008

Authors: Saggar-Malik, AK Afzal, AR Swissman, JS Bland, M Sagnella, GA Eastwood, JB MacGregor, GA Jeffrey, S
Citation: Ak. Saggar-malik et al., Lack of association of ACE/angiotensinogen genotype with renal function inautosomal dominant polycystic kidney disease, GENET TEST, 4(3), 2000, pp. 299-303

Authors: Corbett, JW Ko, SS Rodgers, JD Gearhart, LA Magnus, NA Bacheler, LT Diamond, S Jeffrey, S Klabe, RM Cordova, BC Garber, S Logue, K Trainor, GL Anderson, PS Erickson-Viitanen, SK
Citation: Jw. Corbett et al., Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitors, J MED CHEM, 43(10), 2000, pp. 2019-2030

Authors: Corbett, JW Ko, SS Rodgers, JD Jeffrey, S Bacheler, LT Klabe, RM Diamond, S Lai, CM Rabel, SR Saye, JA Adams, SP Trainor, GL Anderson, PS Erickson-Viitanen, SK
Citation: Jw. Corbett et al., Expanded-spectrum nonnucleoside reverse transcriptase inhibitors inhibit clinically relevant mutant variants of human immunodeficiency virus type 1, ANTIM AG CH, 43(12), 1999, pp. 2893-2897

Authors: Syrris, P Carter, ND Metcalfe, JC Kemp, PR Grainger, DJ Kaski, JC Crossman, DC Francis, SE Gunn, J Jeffrey, S Heathcote, K
Citation: P. Syrris et al., Transforming growth factor-beta gene polymorphisms and coronary artery disease, CLIN SCI, 95(6), 1998, pp. 659-667
Risultati: 1-9 |